Swiss National Bank’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-32,500
Closed -$605K 2539
2023
Q3
$605K Buy
32,500
+1,000
+3% +$18.6K ﹤0.01% 2463
2023
Q2
$818K Hold
31,500
﹤0.01% 2393
2023
Q1
$905K Sell
31,500
-3,700
-11% -$106K ﹤0.01% 2310
2022
Q4
$1.04M Buy
35,200
+1,000
+3% +$29.6K ﹤0.01% 2319
2022
Q3
$814K Hold
34,200
﹤0.01% 2422
2022
Q2
$763K Hold
34,200
﹤0.01% 2495
2022
Q1
$859K Buy
34,200
+2,400
+8% +$60.3K ﹤0.01% 2468
2021
Q4
$1.14M Hold
31,800
﹤0.01% 2405
2021
Q3
$1.35M Buy
31,800
+500
+2% +$21.3K ﹤0.01% 2281
2021
Q2
$1.36M Sell
31,300
-1,200
-4% -$51.9K ﹤0.01% 2335
2021
Q1
$1.33M Buy
32,500
+600
+2% +$24.5K ﹤0.01% 2230
2020
Q4
$1.44M Hold
31,900
﹤0.01% 2103
2020
Q3
$1.13M Hold
31,900
﹤0.01% 2022
2020
Q2
$1.2M Buy
31,900
+4,200
+15% +$159K ﹤0.01% 1998
2020
Q1
$801K Buy
27,700
+1,300
+5% +$37.6K ﹤0.01% 1956
2019
Q4
$1.37M Hold
26,400
﹤0.01% 1949
2019
Q3
$1.45M Hold
26,400
﹤0.01% 1847
2019
Q2
$1.07M Buy
26,400
+900
+4% +$36.5K ﹤0.01% 2077
2019
Q1
$771K Hold
25,500
﹤0.01% 2206
2018
Q4
$857K Hold
25,500
﹤0.01% 2089
2018
Q3
$1.08M Hold
25,500
﹤0.01% 2107
2018
Q2
$816K Hold
25,500
﹤0.01% 2285
2018
Q1
$1.27M Buy
25,500
+1,200
+5% +$59.7K ﹤0.01% 1938
2017
Q4
$1.31M Hold
24,300
﹤0.01% 1922
2017
Q3
$1.41M Hold
24,300
﹤0.01% 1846
2017
Q2
$1.2M Hold
24,300
﹤0.01% 1929
2017
Q1
$1.06M Hold
24,300
﹤0.01% 1994
2016
Q4
$1.19M Buy
24,300
+1,800
+8% +$88.1K ﹤0.01% 1919
2016
Q3
$1.08M Sell
22,500
-1,800
-7% -$86.2K ﹤0.01% 1916
2016
Q2
$1.3M Buy
24,300
+1,000
+4% +$53.7K ﹤0.01% 1803
2016
Q1
$1.01M Buy
23,300
+4,400
+23% +$190K ﹤0.01% 1890
2015
Q4
$721K Hold
18,900
﹤0.01% 2054
2015
Q3
$602K Buy
18,900
+2,500
+15% +$79.6K ﹤0.01% 2082
2015
Q2
$542K Hold
16,400
﹤0.01% 2193
2015
Q1
$675K Buy
16,400
+800
+5% +$32.9K ﹤0.01% 2003
2014
Q4
$636K Hold
15,600
﹤0.01% 2027
2014
Q3
$572K Hold
15,600
﹤0.01% 2014
2014
Q2
$723K Buy
15,600
+900
+6% +$41.7K ﹤0.01% 1922
2014
Q1
$604K Buy
14,700
+3,400
+30% +$140K ﹤0.01% 2025
2013
Q4
$431K Buy
+11,300
New +$431K ﹤0.01% 2081